Quick Takeaways
- BBLG - Bone Biologics Corp has 8 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 8 Insiders of Bone Biologics Corp
- Symbol
- BBLG, BBLGW on Nasdaq
- Location
- Burlington, MA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 10 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Bone Biologics Corp executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Don Hankey | Chairman of the Board, Director, 10%+ Owner | $4,289,289 | Mixed | 27 Mar 2023 | ||
| Robert E. Gagnon | Director | $49,057 | Mixed | 04 Jun 2025 | ||
| Siddhesh Rajendra Angle | Director | $49,057 | Mixed | 04 Jun 2025 | ||
| Phillip Terry Meikle II | Director | $49,057 | Mixed | 04 Jun 2025 | ||
| Bruce Stroever | Director | $49,057 | Mixed | 04 Jun 2025 | ||
| Jeff Frelick | Chief Executive Officer | $25,882 | Mixed | 08 Jan 2026 | ||
| Deina H. Walsh | Chief Financial Officer | $13,144 | Mixed | 08 Jan 2026 | ||
| Erick Lucera | Director | Mixed | 18 Sep 2023 |
Top shareholders of Bone Biologics Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Don Hankey |
3/4/5
|
Chairman of the Board, Director, 10%+ Owner |
—
mixed-class rows
|
7,144,395
mixed-class rows
|
$4,289,289 | — | 27 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
mixed-class rows
|
46,167
mixed-class rows
|
$563,231 | — | 31 Dec 2025 | |
| INTRACOASTAL CAPITAL, LLC |
13D/G
|
Mitchell P. Kopin |
10%
|
199,251
|
$482,187 | +$111,397 | 30 Sep 2025 | |
| Bruce Stroever |
3/4/5
|
Director |
—
class O/S missing
|
62,894
|
$49,057 | — | 04 Jun 2025 | |
| Phillip Terry Meikle II |
3/4/5
|
Director |
—
class O/S missing
|
62,894
|
$49,057 | — | 04 Jun 2025 | |
| Robert E. Gagnon |
3/4/5
|
Director |
—
class O/S missing
|
62,894
|
$49,057 | — | 04 Jun 2025 | |
| Siddhesh Rajendra Angle |
3/4/5
|
Director |
—
class O/S missing
|
62,894
|
$49,057 | — | 04 Jun 2025 | |
| DRW Securities, LLC |
13F
|
Company |
1.2%
|
23,576
|
$34,185 | — | 31 Dec 2025 | |
| Jeff Frelick |
3/4/5
|
Chief Executive Officer |
—
mixed-class rows
|
17,028
mixed-class rows
|
$25,882 | — | 08 Jan 2026 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.56%
|
11,083
|
$16,070 | — | 31 Dec 2025 | |
| Deina H. Walsh |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
8,648
mixed-class rows
|
$13,144 | — | 08 Jan 2026 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
2,248
mixed-class rows
|
$5,825 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.17%
|
3,379
|
$4,900 | — | 31 Dec 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.01%
|
230
|
$334 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
14
|
$20 | — | 31 Dec 2025 | |
| Erick Lucera |
3/4/5
|
Director |
—
class O/S missing
|
85,763
|
— | — | 18 Sep 2023 |
Recent Insider Transactions by Companies or Individuals for Bone Biologics Corp
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Deina H. Walsh | BBLG | Employee Stock Option | Award | 8,335 | 8,335 | 08 Jan 2026 | Direct | |||
| Jeff Frelick | BBLG | Employee Stock Option | Award | 16,668 | 16,668 | 08 Jan 2026 | Direct | |||
| Phillip Terry Meikle II | BBLG | Non-Employee Stock Option | Award | 62,894 | 62,894 | 04 Jun 2025 | Direct | |||
| Siddhesh Rajendra Angle | BBLG | Non-Employee Stock Option | Award | 62,894 | 62,894 | 04 Jun 2025 | Direct | |||
| Bruce Stroever | BBLG | Non-Employee Stock Option | Award | 62,894 | 62,894 | 04 Jun 2025 | Direct | |||
| Robert E. Gagnon | BBLG | Non-Employee Stock Option | Award | 62,894 | 62,894 | 04 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.